Celator Pharmaceuticals Inc
SEC CIK 1327467 · CPXX · last insider filing 2016-07-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kollender Richard S | Director | filed 2013 - 2016 |
| Dougherty Michael R | Director · Executive Chairman | filed 2013 - 2016 |
| Mollica Joseph A | Director | filed 2013 - 2016 |
| Vitullo Nicole | Director | filed 2013 - 2016 |
| Lobacki Joseph M | Director | filed 2013 - 2016 |
| Jackson Scott Thomas | Director · Chief Executive Officer | filed 2013 - 2016 |
| Morenstein Scott D | Director | filed 2013 - 2016 |
| Bizzari Jean-Pierre | Director | filed 2015 - 2016 |
| Zisson Alex | Director | filed 2013 - 2013 |
| Galbraith Kenneth | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Powell Fred M | Vice President and CFO | filed 2013 - 2016 |
| Mayer Lawrence David | See Remarks | filed 2013 - 2016 |
| Wood David | Head of Finance and Corp. Dev. | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.